• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Tomoregulin-1 (TMEFF1), Truncated

ACP02005

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP02005 Target NameTMEFF1
FormLiquid or Lyophilized powderExpression SystemE.coli
Expression Range40-330aaMol Weight35.5 kDa
Protein LengthPartialPurityGreater than 85% as determined by SDS-PAGE.
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ8IYR6
Background Information
  • Uniprot Id

    Q8IYR6

  • Target Species

    Human

  • Target Name

    TMEFF1

  • Target Full Name

    Tomoregulin-1

  • Target Function

    May inhibit NODAL and BMP signaling during neural patterning. May be a tumor suppressor in brain cancers.

  • Target Subcellular Location

    Cell membrane; Single-pass type I membrane protein.

  • Target Protein Families

    Tomoregulin family

  • Target Tissue Specificity

    Expressed predominantly in brain, and at lower levels in heart, placenta and skeletal muscle. Down-regulated in brain tumors as compared to control brain tissues.

  • Target Research Area

    Others

  • Target Synonyms

    C9orf2; C9orf3 TMEFF1; C9orf30 TMEFF1; C9orf30 TMEFF1 fusion protein; Cancer/testis antigen family 120 member 1; CT120.1; H 7365; H7365; MSANTD3-TMEFF1 readthrough; TEFF 1; TEFF1; TEFF1_HUMAN; TMEFF 1; TMEFF1; Tomoregulin-1; Tomoregulin-1 precursor; TR 1; TR-1; TR1; Transmembrane protein with EGF like and two follistatin like domains 1; Transmembrane protein with EGF-like and one follistatin-like domain

Inquire Recombinant Human Tomoregulin-1 (TMEFF1), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification